CVS HEALTH CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.82 USD | +0.25% |
|
-0.14% | -29.31% |
| 08/05 | Argus Research Adjusts Price Target on CVS Health to $80 From $100 | MT |
| 08/05 | Mickey Mouse on Wall Street |  |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 369B 30,807B | Sales 2025 * | 388B 32,400B | Capitalization | 70.07B 5,851B |
|---|---|---|---|---|---|
| Net income 2024 * | 7.66B 640B | Net income 2025 * | 8.92B 745B | EV / Sales 2024 * | 0.32 x |
| Net Debt 2024 * | 48.83B 4,076B | Net Debt 2025 * | 45.01B 3,758B | EV / Sales 2025 * | 0.3 x |
| P/E ratio 2024 * |
9.62
x | P/E ratio 2025 * |
8.22
x | Employees | 2,59,500 |
| Yield 2024 * |
4.77% | Yield 2025 * |
4.72% | Free-Float | 70.67% |
More Fundamentals
* Assessed data
More news
Latest transcript on CVS Health Corporation
More recommendations
More press releases
More news
| 1 day | +0.25% | ||
| 1 week | -0.14% | ||
| Current month | -17.56% | ||
| 1 month | -19.96% | ||
| 3 months | -26.86% | ||
| 6 months | -17.52% | ||
| Current year | -29.31% |
1 week
54.69
57.09
1 month
53.7071.66
Current year
53.7083.25
1 year
53.7083.25
3 years
53.70111.25
5 years
51.72111.25
10 years
51.72113.65
| Managers | Title | Age | Since |
|---|---|---|---|
Karen Lynch
CEO | Chief Executive Officer | 61 | 28/18/28 |
Thomas Cowhey
DFI | Director of Finance/CFO | 51 | 01/22/01 |
David Falkowski
CMP | Compliance Officer | - | 01/11/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Anne Finucane
BRD | Director/Board Member | 71 | 20/11/20 |
Fernando Aguirre
BRD | Director/Board Member | 66 | 28/18/28 |
Mary Schapiro
BRD | Director/Board Member | 68 | 10/17/10 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.92% | 0 M€ | +7.69% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/24/10 | 55.82 | +0.25% | 9,288,418 |
| 09/24/09 | 55.68 | +1.40% | 10,300,491 |
| 08/24/08 | 54.91 | -1.49% | 13,625,329 |
| 07/24/07 | 55.74 | -0.41% | 17,488,119 |
| 06/24/06 | 55.97 | +0.13% | 16,620,136 |
Delayed Quote Nyse, May 11, 2024 at 01:30 am IST
More quotes
CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows:
- medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.;
- retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®);
- medical benefits management (25.8%);
- other (0.1%).
Calendar
14/05/2024
- BofA Securities Health Care Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
55.82
USD
Average target price
71.37
USD
Spread / Average Target
+27.86%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -29.31% | 70.07B | |
| +20.68% | 85.55B | |
| +9.65% | 29.06B | |
| -8.63% | 17.51B | |
| +2.14% | 17.39B | |
| +0.39% | 15.38B | |
| +6.47% | 13.4B | |
| +68.09% | 12.87B | |
| +6.43% | 12.77B | |
| +68.23% | 12.42B |
- Stock Market
- Equities
- CVS Stock